Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 35

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use?

Oyekan, Princess J., Gorton, Hayley C., Copeland, Caroline S. · 2021 · British Journal of Clinical Pharmacology

Abstract

Aims: Antihistamines are routinely taken to control allergic reactions or sedation to induce sleep. There are, however, growing concerns regarding sedating antihistamine misuse. This research aims to evaluate deaths related to antihistamines in England occurring during 2000–2019. Methods: Cases reported to the National Programme on Substance Abuse Deaths from England occurring in 2000–2019 with antihistamine detections at postmortem were extracted for analysis. Results: In total, 1666 antihistamine postmortem detections were identified from 1537 cases. Sedating antihistamines available for purchase under pharmacist supervision but without need for a prescription (pharmacy‐only medications) were present in a significant majority of cases (85.2%, P < .01). Despite an increasing trend for antihistamine‐related deaths over time, the proportion of deaths where an antihistamine was implicated declined over the same period. Specific concerns with regards to the misuse of these pharmacy‐only sedating antihistamines are raised with regards to the significant proportion of cases that were concluded as suicide (20.9%, P < .01), and the high prevalence of their use in combination with other central nervous system depressants (94.8% of cases). Conclusion: This is the first report in over 40 years regarding antihistamine‐related mortality from England. The rising trend in sedating antihistamine‐related deaths may be contributed to by their increasing availability and the perceived negligible dangers associated with antihistamines, both from the general public and learned professionals. Awareness of the dangerous sedative properties that some antihistamines possess is, however, heightened in individuals deliberately seeking these effects. Urgent review of sedating antihistamines currently assigned under the pharmacy‐only classification is needed to achieve antihistamine harm reduction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bcp.14819

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 48

  1. 10.1007/164_2016_85 · DOI
  2. 10.1016/S0301-0082(00)00039-3 · DOI · Paper page
  3. 10.2500/108854188778965528 · doi:10.2500/108854188778965528
  4. Veronika C, 2016, Safety risks of over‐the‐counter (OTC) drugs and their management, Acta Pharm Hung, 86, 151
  5. 10.14423/SMJ.0000000000000256 · DOI
  6. Hedegaard H, 2019, Regional Differences in the Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017, Natl Vital Stat Rep, 68, 1
  7. 10.1111/sltb.12525 · DOI
  8. 10.1016/j.forsciint.2016.10.024 · doi:10.1016/j.forsciint.2016.10.024
  9. 10.3346/jkms.2013.28.10.1424 · doi:10.3346/jkms.2013.28.10.1424
  10. 10.1016/j.jflm.2013.06.027 · DOI
  11. 10.1016/j.forsciint.2006.08.002 · DOI
  12. 10.1016/j.forsciint.2017.11.026 · doi:10.1016/j.forsciint.2017.11.026
  13. 10.1371/journal.pone.0161996 · doi:10.1371/journal.pone.0161996
  14. 10.1097/MCG.0000000000000378 · DOI
  15. 10.1016/j.forsciint.2015.09.021 · DOI
  16. 2019, Deaths related to drug poisoning in England and Wales: 2018 registrations
  17. 10.1136/bmj.280.6231.1595 · doi:10.1136/bmj.280.6231.1595
  18. 10.1093/jat/bku066 · doi:10.1093/jat/bku066
  19. 10.1093/jat/31.9.581 · doi:10.1093/jat/31.9.581
  20. BNF, 2020, British National Formulary 79: April 2020‐ March 2021
  21. Mackridge A, 2013, Time to rethink our approach to misuse of over the counter medicines, Pharm J, 290, 107
  22. 2020, Suicides in England and Wales: 2019 registrations
  23. Wright J, 2016, Changes in over‐the‐counter drug misuse over 20 years: perceptions from Scottish pharmacists, J Public Health (Oxf), 38, 793
  24. 10.3122/jabfm.2008.01.070071 · DOI · Paper page
  25. 10.2165/00002018-200124140-00002 · DOI · Paper page
  26. 10.2165/00002018-200326150-00001 · doi:10.2165/00002018-200326150-00001
  27. 10.3109/14659891.2011.615002 · DOI · Paper page
  28. 10.1097/ADM.0000000000000124 · doi:10.1097/adm.0000000000000124
  29. 10.1097/ADM.0b013e31827f9b43 · DOI
  30. 10.1016/j.drugalcdep.2015.02.023 · doi:10.1016/j.drugalcdep.2015.02.023
  31. 10.1080/02791072.2020.1797250 · DOI
  32. 10.1177/0269881120959615 · DOI
  33. Southard BT, 2020, StatPearls
  34. Sicari V, 2020, StatPearls
  35. 10.1177/106002808401800905 · DOI
  36. 10.1007/s12098-019-02894-8 · doi:10.1007/s12098-019-02894-8
  37. 10.1007/s40278-015-6643-7 · doi:10.1007/s40278-015-6643-7
  38. 10.1186/1477-7517-11-17 · doi:10.1186/1477-7517-11-17
  39. 10.1111/j.1360-0443.2006.01688.x · DOI
  40. 10.1111/add.13843 · DOI · Paper page
  41. 10.1097/ACI.0000000000000556 · doi:10.1097/aci.0000000000000556
  42. 10.1111/j.1398-9995.2009.02325.x · DOI · Paper page
  43. WHO, 2020, Opioid overdose
  44. 10.1192/bjp.187.3.206 · DOI
  45. 10.1136/bmj.f403 · DOI · Paper page
  46. 10.1080/10837450902891485 · DOI
  47. 10.2165/00003088-198916050-00003 · DOI
  48. Alexander SPH, 2019, THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors, Br J Pharmacol, 176, S21

Cited by

See all 35

Metadata

Authors
Oyekan, P. J., Gorton, H. C., & Copeland, C. S.
Affiliations
  • Institute of Pharmaceutical Sciences King's College London London UK
  • Department of Pharmacy, School of Applied Sciences University of Huddersfield Huddersfield UK
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2021-03-31
Volume
87
Issue
10
Pages
3978-3987
ISSN
  • 0306-5251
  • 1365-2125
Cited by
35
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use? https://app.cochat.ai/papers/10.1111/bcp.14819
The paper
Oyekan, P. J., Gorton, H. C., & Copeland, C. S. (2021). Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use? British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14819

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.